India's first COVID-19 vaccine Covaxin journey: From test results to phase 3 trial, latest updates

- Covaxin is currently in the phase II clinical trial in the country
- Covaxin will use adjuvant Alhydroxiquim-II to boost immune response and longer lasting immunity, Bharat Biotech said